Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Haskell

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Investigational New Drugs|September 18, 1998
Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancerC M Haskell, E Mendoza, K M Pisters, et al.
Cancer|April 1, 1989
Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?P A Ganz, R A Figlin, C M Haskell, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1970
Clinical experience with L-asparaginaseP P Carbone, C M Haskell, B G Leventhal, et al.
Cancer Treatment Reports|May 1, 1978
Chemo-immunotherapy for unresectable bronchogenic carcinomaG P Sarna, B B Lowitz, C M Haskell, et al.
The Journal of Experimental Medicine|August 1, 1983
Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude miceF Buchegger, C M Haskell, M Schreyer, et al.
Lancet (London, England)|October 13, 1973
Granulomatous hepatitis: a complication of B.C.G. immunotherapyJ S Hunt, M J Silverstein, F C Sparks, et al.
Clinical and Experimental Immunology|July 1, 1983
Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosisW W Shih, R W Baumhefner, W W Tourtellotte, et al.
The New England Journal of Medicine|October 18, 1973
Complications of BCG immunotherapy in patients with cancerF C Sparks, M J Silverstein, J S Hunt, et al.
Clinical Chemistry|October 1, 1981
Increased inactive creatine kinase B protein in the plasma of patients with malignancyM H Burnam, J L Barstis, C S Stern, et al.
National Cancer Institute Monograph|June 1, 1982
Clinical radiofrequency hyperthermia: a reviewF K Storm, D L Morton, L R Kaiser, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|September 18, 1998
Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and stage IV non-small cell lung cancerC M Haskell, E Mendoza, K M Pisters, et al.
Cancer|April 1, 1989
Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?P A Ganz, R A Figlin, C M Haskell, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1970
Clinical experience with L-asparaginaseP P Carbone, C M Haskell, B G Leventhal, et al.
Cancer Treatment Reports|May 1, 1978
Chemo-immunotherapy for unresectable bronchogenic carcinomaG P Sarna, B B Lowitz, C M Haskell, et al.
The Journal of Experimental Medicine|August 1, 1983
Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude miceF Buchegger, C M Haskell, M Schreyer, et al.
Lancet (London, England)|October 13, 1973
Granulomatous hepatitis: a complication of B.C.G. immunotherapyJ S Hunt, M J Silverstein, F C Sparks, et al.
Clinical and Experimental Immunology|July 1, 1983
Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosisW W Shih, R W Baumhefner, W W Tourtellotte, et al.
The New England Journal of Medicine|October 18, 1973
Complications of BCG immunotherapy in patients with cancerF C Sparks, M J Silverstein, J S Hunt, et al.
Clinical Chemistry|October 1, 1981
Increased inactive creatine kinase B protein in the plasma of patients with malignancyM H Burnam, J L Barstis, C S Stern, et al.
National Cancer Institute Monograph|June 1, 1982
Clinical radiofrequency hyperthermia: a reviewF K Storm, D L Morton, L R Kaiser, et al.
Pageof 5